第一单位：
Hematology and Cellular Therapy Department, Saint-Antoine Hospital, Pierre & Marie Curie University, Paris, France. Electronic address: mohamad.mohty@inserm.fr.
作者：
Mohamad,Mohty [1]
;
Evangelos,Terpos [2]
;
Maria-Victoria,Mateos [3]
;
Michele,Cavo [4]
;
Sandra,Lejniece [5]
;
Meral,Beksac [6]
;
Mohamed Amine,Bekadja [7]
;
Wojciech,Legiec [8]
;
Meletios,Dimopoulos [2]
;
Svetlana,Stankovic [9]
;
Maria Soledad,Durán [10]
;
Valerio,De Stefano [11]
;
Alessandro,Corso [12]
;
Yulia,Kochkareva [13]
;
Edward,Laane [14]
;
Christian,Berthou [15]
;
Hans,Salwender [16]
;
Zvenyslava,Masliak [17]
;
Valdas,Pečeliūnas [18]
;
Wolfgang,Willenbacher [19]
;
João,Silva [20]
;
Vernon,Louw [21]
;
Damir,Nemet [22]
;
Zita,Borbényi [23]
;
Uri,Abadi [24]
;
Robert Schou,Pedersen [25]
;
Peter,Černelč [26]
;
Anna,Potamianou [27]
;
Catherine,Couturier [28]
;
Caroline,Feys [29]
;
Florence,Thoret-Bauchet [28]
;
Mario,Boccadoro [30]
;
EMMOS Investigators
作者单位：
Hematology and Cellular Therapy Department, Saint-Antoine Hospital, Pierre & Marie Curie University, Paris, France. Electronic address: mohamad.mohty@inserm.fr.
[1]
Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.
[2]
Servicio de Hematologia, Hospital Universitario de Salamanca, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Cellular del Cáncer (Universitario de Salamanca-Consejo Superior de Investigaciones Científicas), Salamanca, Spain.
[3]
Seràgnoli Institute of Hematology, University of Bologna, Bologna, Italy.
[4]
Department of Doctoral Studies, Riga Stradiņš University, Riga, Latvia.
[5]
Department of Hematology, Ankara University, Ankara, Turkey.
[6]
Hematology and Cell Therapy, Etablissement Hospitalier Universitaire, Oran, Algeria.
[7]
Department Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
[8]
University Clinic of Hematology, Medical Faculty, Skopje, Macedonia.
[9]
Hematologia, Complejo Hospitalario de Jaén, Jaén, Spain.
[10]
Institute of Hematology, Catholic University, Rome, Italy.
[11]
Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy.
[12]
State Budget Healthcare Institution of Moscow, City Outpatient Clinic, 68 of Healthcare Department of Moscow, Branch 3, Moscow, Russia.
[13]
North Estonia Medical Centre Foundation, Tallinn, Estonia.
[14]
Université de Bretagne Occidentale, Brest, France.
[15]
Multiples Myelom, Asklepios Klinik Altona, Hamburg, Germany.
[16]
Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine.
[17]
Hematology, Oncology, and Transfusion Medicine Center, Vilnius University Hospital, Santariskiu Klinikos, Vilnius, Lithuania.
[18]
Universitätsklinik Innsbruck Innere Medizin V, and Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria.
[19]
Department of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada.
[20]
Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa.
[21]
Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
[22]
Szegedi Tudomanyegyetem, II. Belgyógyászati Klinika, Szeged, Hungary.
[23]
Hematology, Meir Medical Center, Kfar Saba, Israel.
[24]
Regionshospitalet i Holstebro, Medicinsk Afdeling, Holstebro, Denmark.
[25]
Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
[26]
Janssen-Cilag, Neuss, Germany.
[27]
Janssen-Cilag, Issy-les-Moulineaux, France.
[28]
Janssen Research and Development, Beerse, Belgium.
[29]
Myeloma Unit, Division of Hematology, Città della Salute e della Scienza, University of Torino, Turin, Italy.
[30]
DOI
10.1016/j.clml.2018.06.018
PMID
30030033
发布时间
2019-10-22
换一批
换一批
